{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:44:35Z","timestamp":1780447475754,"version":"3.54.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Health and Family Planning Commission of Shanghai, China","award":["201640310"],"award-info":[{"award-number":["201640310"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Ileocolonoscopy is currently recognized as the gold standard for evaluating mucosal healing in patients with Crohn disease (CD). However, the ideal noninvasive marker to assess mucosal healing instead of invasive ileocolonoscopy is not available. This study aimed to determine the correlations between the mucosal healing and serological optimizing markers in CD.<\/jats:p>\n            <jats:p>This retrospective study consecutively included 62 CD patients with 137 hospitalizations between March 2014 and March 2020. On the basis of the Simple Endoscopic Score for Crohn's disease (SES-CD), the CD patients were divided into mucosal healing group (SES-CD \u2264 2) and nonmucosal healing group (SES-CD\u200a&gt;\u200a2). We collected the results of ileocolonoscopy examination and inflammatory markers and then serological optimizing markers, including C-reactive protein\/albumin ratio (CRP\/ALB), platelet\/albumin ratio (PLT\/ALB), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) were calculated. The control group consisted of 50 healthy volunteers in the corresponding period.<\/jats:p>\n            <jats:p>We found that CRP\/ALB, PLT\/ALB, NLR, and PLR were correlated with the mucosal healing of CD, and the correlation of CRP\/ALB with the mucosal healing was the highest (<jats:italic toggle=\"yes\">r<\/jats:italic>\u200a=\u200a-0.64). Receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) of CRP\/ALB (0.87) was higher than NLR (0.69), PLR (0.72), and PLT\/ALB (0.81). In the efficacy of assessing the mucosal healing in CD, the sensitivity of CRP\/ALB, NLR, PLR, and PLT\/ALB were 91.1%, 83.9%, 73.2%, and 73.2%, respectively, and the specificity was 76.5%, 46.9%, 64.2%, and 75.3%, respectively.<\/jats:p>\n            <jats:p>CRP\/ALB was the most appropriate marker to assess CD mucosal healing among the serological optimizing markers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024925","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:03:31Z","timestamp":1615511011000},"page":"e24925","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["C-reactive protein\/abumin ratio is a useful biomarker for predicting the mucosal healing in the Crohn disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Fu-Sheng","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Huashan Hospital North, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Qi","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Huashan Hospital North, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/apt.12949","article-title":"Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation","volume":"40","author":"Schulze","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.crohns.2011.07.003","article-title":"Results of the 2nd part Scientific Workshop of the ECCO. II: measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease","volume":"5","author":"Daperno","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2012.01.035","article-title":"Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial","volume":"142","author":"Rutgeerts","year":"2012","journal-title":"Gastroenterology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/gutjnl-2015-309903","article-title":"IOIBD technical review on endoscopic indices for Crohn's disease clinical trials","volume":"65","author":"Vuitton","year":"2016","journal-title":"Gut"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOG.0000000000000076","article-title":"Serological studies in inflammatory bowel disease: how important are they?","volume":"30","author":"Papp","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R12-20250504","first-page":"1386","article-title":"Predicting endoscopic Crohn's disease activity before and after induction therapy in children: a comprehensive assessment of PCDAI, CRP, and fecal calprotectin","volume":"21","author":"Zubin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ecco-jcc\/jjv150","article-title":"Endoscopic factors influencing fecal calprotectin value in Crohn's Disease","volume":"9","author":"Goutorbe","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/MIB.0000000000001202","article-title":"Fecal calprotectin more accurately predicts endoscopic remission of Crohn's Disease than serological biomarkers evaluated using balloon-assisted enteroscopy","volume":"23","author":"Kawashima","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15063","article-title":"Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: a simple algorithm for clinical practice","author":"Pauwels","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10350-008-9310-8","article-title":"Review of fecal biomarkers in inflammatory bowel disease","volume":"51","author":"Sutherland","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R17-20250504","first-page":"702","article-title":"Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United European","volume":"5","author":"Marechal","year":"2017","journal-title":"Gastroenterol J"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10350-007-0303-9","article-title":"Accuracy of four fecal assays in the diagnosis of colitis","volume":"50","author":"Schoepfer","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/MIB.0000000000001140","article-title":"Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease","volume":"23","author":"Buisson","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","article-title":"Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings","volume":"14","author":"Sipponen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/j.crohns.2013.06.008","article-title":"Serum calprotectin as a biomarker for Crohn's disease","volume":"7","author":"Meuwis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R22-20250504","first-page":"14779","article-title":"Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.12659\/MSM.897460","article-title":"Serum albumin and C-reactive protein\/albumin ratio are useful biomarkers of Crohn's disease activity","volume":"22","author":"Qin","year":"2016","journal-title":"Med Sci Monit"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cgh.2016.04.033","article-title":"Intestinal dilation and platelet: albumin ratio are predictors of surgery in stricturing small bowel Crohn's disease","volume":"14","author":"Stidham","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/1319-3767.182455","article-title":"Implementation of the simple endoscopic activity. score in crohn's disease","volume":"22","author":"Koutroumpakis","year":"2016","journal-title":"Saudi J Gastroenterol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term. outcome of maintenance therapy with infliximab in Crohn's disease","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/ajg.2010.78","article-title":"Increased response and remission. rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data","volume":"105","author":"Schreiber","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41598-020-57508-7","article-title":"Serum C-reactive protein and albumin are useful. biomarkers for tight control management of Crohn's disease in Japan","volume":"10","author":"Shiga","year":"2020","journal-title":"Sci Rep"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmed.2020.00123","article-title":"Serum biomarkers for inflammatory bowel disease","volume":"7","author":"Chen","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7861\/clinmedicine.9-1-30","article-title":"Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive. protein\/albumin ratio as a predictor of patient outcome","volume":"9","author":"Fairclough","year":"2009","journal-title":"Clin Med (Lond)"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00268-017-4400-1","article-title":"Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients","volume":"42","author":"Saito","year":"2018","journal-title":"World J Surg"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/17474124.2014.893821","article-title":"C-reactive protein in Crohn's disease: how informative is it?","volume":"8","author":"Magro","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2018.01.024","article-title":"Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn's disease","volume":"16","author":"Weinstein-Nakar","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"(4 Suppl 2)","key":"R38-20250504","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/01.mcg.0000155514.17715.39","article-title":"Inhibition of albumin synthesis in chronic diseases: molecular mechanisms","volume":"39","author":"Chojkier","year":"2005","journal-title":"J Clin Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:04:13Z","timestamp":1746338653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024925"}},"subtitle":["A retrospective study"],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024925","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"2020-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}